Page 6 - Flipbook
P. 6
LEARNING OBJECTIVES
By participating in this learning program, health care providers can
expect to:
• Describe the hormonal therapy continuum for prostate cancer, including
the role of androgen deprivation therapy (ADT) as the backbone of
therapy
• Explain the rationale for earlier treatment with hormonal therapies in
patients with high-risk prostate cancer
• Discuss strategies to minimize the potential cardiovascular (CV) side
effects of ADT
• Review recent advances in the treatment of advanced prostate cancer
